Marta Cova

Marta Cova

Auto-generated profile, based on publicly available information

Marta Cova

ISGlobal, Barcelona Ctr. Int. Health Res. (CRESIB), Hospital Clínic - Universitat de Barcelona, Barcelona, Spain

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 January 2015 in Applied Microbiology and Biotechnology
Verified
Journal Article
Closed access
PDF file
Joao Pinto da CostaJoao Pinto da Costa
Joao Pinto da Costa
MCMarta Cova
Marta Cova
RFRita Ferreira
Rita Ferreira
Rui VitorinoRui Vitorino
Rui Vitorino

31 October 2015 in Malaria Journal
Verified
Journal Article
Open access
PDF file
MCMarta Cova
Marta Cova
JRJoão A. Rodrigues
João A. Rodrigues
Terry SmithTerry Smith
Terry Smith
LILuis Izquierdo
Luis Izquierdo
Glycoconjugates are important mediators of host-pathogen interactions and are usually very abundant in the surface of many protozoan parasites. However, in the particular case of Plasmodium species, previous works show that glycosylphosphatidylinositol anchor modifications, and to an unknown extent, a severely truncated N-glycosylation are the only glycosylation processes taking place in the parasite. Nevertheless, a detailed analysis of the parasite genome and the recent identification of the sugar nucleotide precursors biosynthesized by Plasmodium falciparum support a picture in which several overlooked, albeit not very prominent glycosylations may be occurring during the parasite life cycle. In this work, the authors review recent developments in the characterization of the biosynthesis of glycosylation precursors in the parasite, focusing on the outline of the possible fates of these precursors.

11 July 2022 in Nature Microbiology
Verified
Journal Article
Closed access
PDF file
MMMatthew Martinez
Matthew Martinez
WCWilliam David Chen
William David Chen
MCMarta Mendonça Cova
Marta Mendonça Cova
PMPetra Molnár
Petra Molnár
SMShrawan Kumar Mageswaran
Shrawan Kumar Mageswaran
YCYi-Wei Chang
Yi-Wei Chang

9 March 2015 in Proteomics
Verified
Journal Article
Closed access
PDF file
PSPatrícia de Sousa‐Pereira
Patrícia de Sousa‐Pereira
MCMarta Cova
Marta Cova
JAJoana Abrantes
Joana Abrantes
RFRita Ferreira
Rita Ferreira
FTFábio Trindade
Fábio Trindade
Rui VitorinoRui Vitorino
Rui Vitorino

17 October 2022 in The EMBO Journal
Verified
Journal Article
Open access
DSDaniela Sparvoli
Daniela Sparvoli
JDJason Delabre
Jason Delabre
DPDiana Marcela Penarete‐Vargas
Diana Marcela Penarete‐Vargas
SMShrawan Kumar Mageswaran
Shrawan Kumar Mageswaran
LTLev M Tsypin
Lev M Tsypin
MLMaryse Lebrun
Maryse Lebrun
Apicomplexan parasites possess secretory organelles called rhoptries that undergo regulated exocytosis upon contact with the host. This process is essential for the parasitic lifestyle of these pathogens and relies on an exocytic machinery sharing structural features and molecular components with free‐living ciliates. However, how the parasites coordinate exocytosis with host interaction is unknown. Here, we performed a Tetrahymena ‐based transcriptomic screen to uncover novel exocytic factors in Ciliata and conserved in Apicomplexa. We identified membrane‐bound proteins, named CRMPs, forming part of a large complex essential for rhoptry secretion and invasion in Toxoplasma . Using cutting‐edge imaging tools, including expansion microscopy and cryo‐electron tomography, we show that, unlike previously described rhoptry exocytic factors, TgCRMPs are not required for the assembly of the rhoptry secretion machinery and only transiently associate with the exocytic site—prior to the invasion. CRMPs and their partners contain putative host cell‐binding domains, and CRMPa shares similarities with GPCR proteins. Collectively our data imply that the CRMP complex acts as a host–molecular sensor to ensure that rhoptry exocytosis occurs when the parasite contacts the host cell.

28 July 2016 in Scientific Reports
Verified
Journal Article
Open access
AHAna Gabriela Henriques
Ana Gabriela Henriques
TMThorsten Müller
Thorsten Müller
JOJoana Machado Oliveira
Joana Machado Oliveira
MCMarta Cova
Marta Cova
CSCristóvão B. da Cruz e Silva
Cristóvão B. da Cruz e Silva
Odete A. B. Da Cruz E SilvaOdete A. B. Da Cruz E Silva
Odete A. B. Da Cruz E Silva
The amyloidogenic peptide, Aβ, provokes a series of events affecting distinct cellular pathways regulated by protein phosphorylation. Aβ inhibits protein phosphatases in a dose-dependent manner, thus it is expected that the phosphorylation state of specific proteins would be altered in response to Aβ. In fact several Alzheimer’s disease related proteins, such as APP and TAU, exhibit pathology associated hyperphosphorylated states. A systems biology approach was adopted and the phosphoproteome, of primary cortical neuronal cells exposed to Aβ, was evaluated. Phosphorylated proteins were recovered and those whose recovery increased or decreased, upon Aβ exposure across experimental sets, were identified. Significant differences were evident for 141 proteins and investigation of their interactors revealed key protein clusters responsive to Aβ treatment. Of these, 73 phosphorylated proteins increased and 68 decreased upon Aβ addition. These phosphorylated proteins represent an important resource of potential AD phospho biomarkers that should be further pursued.